Metheptazine
Appearance
Clinical data | |
---|---|
Other names | Metheptazine |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H23NO2 |
Molar mass | 261.36 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Metheptazine is an opioid analgesic from the phenazepine family. It was developed by American Home Products in the 1950s.[1]
Metheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.
Metheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[2] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.
References
- ^ US Patent 2740777 PROCESS FOR THE PREPARATION OF HEXAHYDRO-1,3-DIMETHYL- 4-PHENYLAZEPINE-4-CARBOXYLIC ACID, ETHYL ESTER
- ^ http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html